Poniard Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of innovative oncology products. For additional information please visit http://www.poniard.com.
Quote | Poniard Pharms Inc (OTCMKTS:PARD)
Last: | $0.0001 |
---|---|
Change Percent: | 0.0% |
Open: | $0 |
Close: | $0.0001 |
High: | $0 |
Low: | $0 |
Volume: | 7 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
News | Poniard Pharms Inc (OTCMKTS:PARD)
Message Board Posts | Poniard Pharms Inc (OTCMKTS:PARD)
Subject | By | Source | When |
---|---|---|---|
Stock_Tracker: Latest Poniard Pharmaceuticals (PARD) Headlines Verastem Acquires Rights to Cancer St | Stock_Tracker | investorshangout | 03/11/2014 2:48:18 AM |
chartguy89: PARD 0.3351 Stock Charts $PARD 1 Month Chart | chartguy89 | investorshangout | 03/09/2014 7:51:02 AM |
chartguy89: PARD Stock Charts Last: -0.105 Friday, February 28, 2014 at 2:53:35 PM $PARD 1 M | chartguy89 | investorshangout | 02/28/2014 7:53:47 PM |
OK, what's up with the jump? No | workyourmoney | investorshub | 08/07/2013 3:59:43 PM |
Any news from $PARD...? | Attote | investorshub | 11/04/2012 7:20:34 PM |